We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+14.6%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$9.2B
AUM Growth
+$972M
Cap. Flow
-$111M
Cap. Flow %
-1.21%
Top 10 Hldgs %
15.57%
Holding
2,653
New
86
Increased
398
Reduced
774
Closed
85

Sector Composition

Rank Sector Weight
1 Technology 16.51%
2 Financials 14.36%
3 Healthcare 13.08%
4 Industrials 10.1%
5 Consumer Discretionary 9.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BCRX icon
1576
BioCryst Pharmaceuticals
BCRX
$2.51B
$412K ﹤0.01%
50,588
KAI icon
1577
Kadant
KAI
$3.91B
$411K ﹤0.01%
4,675
CNS icon
1578
Cohen & Steers
CNS
$4.4B
$410K ﹤0.01%
9,693
CISN
1579
DELISTED
Cision Ltd. Ordinary Share
CISN
$409K ﹤0.01%
29,687
ANGO icon
1580
AngioDynamics
ANGO
$647M
$408K ﹤0.01%
17,852
MTSC
1581
DELISTED
MTS Systems Corp
MTSC
$407K ﹤0.01%
7,482
STNG icon
1582
Scorpio Tankers
STNG
$3.93B
$407K ﹤0.01%
20,512
-1
-0% -$19
OSG
1583
Octave Specialty Group
OSG
$212M
$407K ﹤0.01%
22,444
WIFI
1584
DELISTED
Boingo Wireless, Inc.
WIFI
$405K ﹤0.01%
17,390
UTL icon
1585
Unitil
UTL
$992M
$402K ﹤0.01%
7,429
RGR icon
1586
Sturm, Ruger & Co
RGR
$601M
$400K ﹤0.01%
7,553
MBI icon
1587
MBIA
MBI
$262M
$399K ﹤0.01%
41,874
MODV
1588
DELISTED
ModivCare
MODV
$398K ﹤0.01%
5,978
NHC icon
1589
National Healthcare
NHC
$3.44B
$398K ﹤0.01%
5,246
VIVO
1590
DELISTED
Meridian Bioscience Inc
VIVO
$397K ﹤0.01%
22,552
ATKR icon
1591
Atkore
ATKR
$3.17B
$397K ﹤0.01%
18,445
SRI icon
1592
Stoneridge
SRI
$201M
$396K ﹤0.01%
13,705
GCO icon
1593
Genesco
GCO
$394M
$396K ﹤0.01%
8,683
LILA icon
1594
Liberty Latin America Class A
LILA
$1.67B
$394K ﹤0.01%
31,853
AMKR icon
1595
Amkor Technology
AMKR
$14.3B
$394K ﹤0.01%
46,149
OFG icon
1596
OFG Bancorp
OFG
$2.26B
$394K ﹤0.01%
19,884
DBD
1597
DELISTED
Diebold Nixdorf Incorporated
DBD
$392K ﹤0.01%
35,435
ABR icon
1598
Arbor Realty Trust
ABR
$981M
$392K ﹤0.01%
30,231
+295
+1% +$3.58K
MDGL icon
1599
Madrigal Pharmaceuticals
MDGL
$11.7B
$391K ﹤0.01%
3,123
EVH icon
1600
Evolent Health
EVH
$527M
$391K ﹤0.01%
31,066

Similar funds

MetLife Investment Management's Q1 2019 Portfolio in Review

As of Q1 2019, MetLife Investment Management held 2,653 positions worth $9.2B, up 12% from $8.23B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

MetLife Investment Management's Q1 2019 filing shows 86 new, 398 increased, 774 reduced and 85 closed positions. Its largest new stake was Linde: 156,645 shares worth $27.6M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $48.3M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

  • MetLife Investment Management's largest Q1 2019 buy was Linde: 156,645 shares worth $27.6M.
  • MetLife Investment Management added most to Western Midstream Partners in Q1 2019, an estimated $10.9M increase.
  • MetLife Investment Management's biggest Q1 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $48.3M.
  • MetLife Investment Management fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $14.5M.
  • MetLife Investment Management's ten largest holdings make up 16% of its $9.2B portfolio in Q1 2019.
  • MetLife Investment Management opened 86 new positions and closed 85 in Q1 2019.
  • MetLife Investment Management's portfolio value rose 12% quarter-over-quarter to $9.2B.

Based on MetLife Investment Management's 13F filing for Q1 2019, filed 15 May 2019.